Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsR&D In ProcessShares Outstanding
Ratios

Tandem Diabetes Care (TNDM) R&D In Process (2022 - 2025)

Historic R&D In Process for Tandem Diabetes Care (TNDM) over the last 3 years, with Q1 2025 value amounting to $75.2 million.

  • Tandem Diabetes Care's R&D In Process changed N/A to $75.2 million in Q1 2025 from the same period last year, while for Sep 2025 it was $75.2 million, marking a year-over-year change of. This contributed to the annual value of $78.8 million for FY2023, which is 15371.31% up from last year.
  • Tandem Diabetes Care's R&D In Process amounted to $75.2 million in Q1 2025.
  • Over the past 5 years, Tandem Diabetes Care's R&D In Process peaked at $78.8 million during Q1 2023, and registered a low of $23000.0 during Q4 2022.
  • Over the past 3 years, Tandem Diabetes Care's median R&D In Process value was $53.1 million (recorded in 2022), while the average stood at $46.3 million.